Showing results (321-330 of 552) with videos related to

Sort By:
Pageof 56
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|April 17, 2001
Physician-based activity counseling: intervention effects on mediators of motivational readiness for physical activityB M Pinto, H Lynn, B H Marcus, et al.
The Journal of Experimental Medicine|March 1, 1984
Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell bindingW E Biddison, P E Rao, M A Talle, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1978
Age, thymic involution, and circulating thymic hormone activityV M Lewis, J J Twomey, P Bealmear, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 13, 2006
Pseudomyxoma peritonei arising from colonic polypsP J G Goldstein, J Cabanas, R G da Silva, et al.
Psychonomic Bulletin & Review|June 17, 2010
From recognition to decisions: extending and testing recognition-based models for multialternative inferenceJulian N Marewski, Wolfgang Gaissmaier, Lael J Schooler, et al.
Nephron|January 1, 1987
Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulinC F Shield, D J Norman, P Marlett, et al.
Blood|November 1, 1985
Null cell identification and characterization with OKT16: an anti-p40 monoclonal antibodyM A Talle, P Rao, M Makowski, et al.
Alcoholism, Clinical and Experimental Research|March 1, 1984
Adolescent sons of alcoholics: neuropsychological and personality characteristicsR E Tarter, A M Hegedus, G Goldstein, et al.
Biological Psychiatry|June 1, 1993
A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranesN J Minshew, G Goldstein, S M Dombrowski, et al.
Journal of Clinical Immunology|July 1, 1982
Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot studyA H Filipovich, P McGlave, N K Ramsay, et al.
Pageof 56